Availability of Clinical Measures for Patients with Rheumatoid Arthritis in Integrated Delivery Networks who Receive a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: A Real-World Analysis of an Electronic Health Records Database

Chastek Benjamin; Chen Chieh-I; Kimura Toshio; Fay Jonathan; Korrer Stephanie; Fiore Stefano

首页> 外文期刊>The Journal of rheumatology >Availability of Clinical Measures for Patients with Rheumatoid Arthritis in Integrated Delivery Networks who Receive a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: A Real-World Analysis of an Electronic Health Records Database

【24h】

Availability of Clinical Measures for Patients with Rheumatoid Arthritis in Integrated Delivery Networks who Receive a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: A Real-World Analysis of an Electronic Health Records Database

机译：综合交付网络中的类风湿性关节炎患者的临床措施的可用性，受到生物或有针对性的合成疾病改性的抗漏毒药物的：对电子健康记录数据库的实际分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of rheumatology》 |2018年第7期|共1页
作者
Chastek Benjamin; Chen Chieh-I; Kimura Toshio; Fay Jonathan; Korrer Stephanie; Fiore Stefano;
展开▼
作者单位

Optum Eden Prairie MN USA;

Regeneron Pharmaceut Inc 777 Old Saw Mill River Rd Tarrytown NY 10591 USA;

Regeneron Pharmaceut Inc 777 Old Saw Mill River Rd Tarrytown NY 10591 USA;

Regeneron Pharmaceut Inc 777 Old Saw Mill River Rd Tarrytown NY 10591 USA;

Optum Eden Prairie MN USA;

Sanofi Genzyme Bridgewater MA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
专利

1. Availability of Clinical Measures for Patients with Rheumatoid Arthritis in Integrated Delivery Networks who Receive a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: A Real-World Analysis of an Electronic Health Records Database [J] . Chastek Benjamin, Chen Chieh-I, Kimura Toshio, The Journal of rheumatology . 2018,第7期

机译：综合交付网络中的类风湿性关节炎患者的临床措施的可用性，受到生物或有针对性的合成疾病改性的抗漏毒药物的：对电子健康记录数据库的实际分析
2. Original article: Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting [J] . Huifang Liang, Raghava Danwada, Dianlin Guo, RMD Open . 2019,第2期

机译：原始文章：治疗类风湿性关节炎患者的住院静脉血栓栓塞发生率，以及与在现实环境中转换生物制剂或靶向合成疾病修饰抗风湿药（DMARD）的关联
3. Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan- European TOCERRA register collaboration [J] . Lauper Kim, Nordstrom Dan C., Pavelka Karel, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第9期

机译：与TNF抑制剂与TNF抑制剂的比较有效性作为单药治疗或与常规的合成疾病改性抗逆素药物在使用至少一种生物学疾病改性的抗腹性药物后用类风湿性关节炎患者：从泛欧托拉登记协作分析
4. Predicting Clinical Diagnosis from Patients Electronic Health Records Using BERT-Based Neural Networks [C] . Pavel Blinov, Manvel Avetisian, Vladimir Kokh, International Conference on Artificial Intelligence in Medicine . 2020

机译：使用基于伯特的神经网络预测患者电子健康记录的临床诊断
5. Original article: Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting [O] . Huifang Liang, Raghava Danwada, Dianlin Guo, 2019

机译：原始文章：类风湿关节炎患者的住院静脉血栓栓塞发生率以及与在现实环境中转换生物制剂或靶向合成疾病修饰抗风湿药（DMARDs）的关联
6. Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting [O] . Huifang Liang, Raghava Danwada, Dianlin Guo, 2019

机译：病毒关节炎患者的入口静脉血栓栓塞的发病率和与现实世界环境中的转换生物学或靶向综合疾病改性抗胃（DMARDS）的关联

Availability of Clinical Measures for Patients with Rheumatoid Arthritis in Integrated Delivery Networks who Receive a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: A Real-World Analysis of an Electronic Health Records Database

著录项

相似文献

相关主题

期刊订阅